Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 24.28 USD | -1.18% |
|
-3.61% | +49.51% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
| Market Cap | 3.87B 3.33B 3.14B 2.87B 5.36B 366B 5.38B 37.07B 14.39B 188B 14.55B 14.23B 605B | P/E 2026 * |
-44.6x | P/E 2027 * | -137x |
|---|---|---|---|---|---|
| Enterprise Value | 3.82B 3.28B 3.09B 2.82B 5.28B 360B 5.29B 36.51B 14.17B 185B 14.33B 14.02B 596B | EV / Sales 2026 * |
13x | EV / Sales 2027 * | 10.5x |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Tradegate
| 1HM | Real-time | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Börse Stuttgart
| 1HM | Delayed |
Last Transcript : Adaptive Biotechnologies Corporation
| 1 day | -1.18% | ||
| 1 week | -3.61% | ||
| Current month | -2.57% | ||
| 1 month | -1.30% | ||
| 3 months | +43.67% | ||
| 6 months | +52.42% | ||
| Current year | +49.51% |
| 1 week | 23.84 |  | 25.36 |
| 1 month | 23.84 | | 26.87 |
| Current year | 12 | | 26.87 |
| 1 year | 12 | | 26.87 |
| 3 years | 2.28 | | 26.87 |
| 5 years | 2.28 | | 40 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Don | Director | -12,539 | 0.0078% | ||
| 26/08/26 | Sell | Director | -9,615 | 0.0060% | ||
| 18/08/26 | Exercice | Director | 60,664 | 0.0379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | -3.61% | +88.95% | +265.66% | 3.87B | |
| +1.03% | +9.74% | +253.01% | +45.53% | 3.98B | |
| -4.79% | -1.87% | +31.14% | +62.45% | 3.42B | |
| +2.05% | +2.19% | +268.16% | +456.67% | 2.63B | |
| -1.65% | -6.73% | -27.81% | -31.56% | 2.11B | |
| -3.49% | +10.28% | +54.60% | - | 1.75B | |
| -0.68% | -4.69% | +191.63% | -27.45% | 1.09B | |
| +1.11% | -10.52% | +23.40% | +42.09% | 1.08B | |
| -1.55% | -11.92% | +2.47% | +49.84% | 609M | |
| +0.33% | -4.13% | -33.17% | -5.50% | 527M | |
| Average | -0.88% | -0.77% | +85.24% | +95.30% | 2.11B | |
| Weighted average by Cap. | -1.01% | +0.71% | +114.83% | +134.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 252M 237M 217M 406M 27.69B 407M 2.81B 1.09B 14.21B 1.1B 1.08B 45.76B | 359M 309M 290M 265M 496M 33.85B 497M 3.43B 1.33B 17.37B 1.35B 1.32B 55.95B |
| Net income | -85.78M -73.81M -69.45M -63.44M -119M -8.1B -119M -821M -318M -4.16B -322M -315M -13.39B | -27.55M -23.71M -22.31M -20.38M -38.12M -2.6B -38.22M -264M -102M -1.33B -103M -101M -4.3B |
| Net Debt | -58.99M -50.76M -47.76M -43.63M -81.62M -5.57B -81.84M -564M -219M -2.86B -222M -217M -9.21B | -104M -89.35M -84.06M -76.79M -144M -9.8B -144M -993M -385M -5.03B -390M -381M -16.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $24.28 | -1.18% | 1,404,316 |
| 03/09/26 | $24.57 | -0.36% | 2,161,036 |
| 02/09/26 | $24.66 | +1.31% | 1,623,149 |
| 01/09/26 | $24.34 | -2.33% | 1,621,010 |
| 31/08/26 | $24.92 | -1.07% | 2,237,634 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
